Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours

European Journal of Surgical Oncology

Volumn 31, Issue 2, 2005, Pages 128-133

  Fiets, W E ^a   Bellot, F E ^b   Struikmans, H ^c   Blankenstein, M A ^d   Nortier, J W R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Infection and Immunology   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast neoplasm; Mitotic index; Prognosis; Reproducibility

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FOLLOW UP; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; LYMPH NODE BIOPSY; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION; TUMOR VOLUME;

AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MIDDLE AGED; MITOTIC INDEX; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; STATISTICS; SURVIVAL ANALYSIS; WOMEN'S HEALTH;

EID: 13444309705     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.08.012     Document Type: Article

References (24)

1. A. Goldhirsch J.H. Glick R.D. Gelber A.S. Coates H.-J. Senn Meeting highlights: International consensus panel on the treatment of primary breast cancer J Clin Oncol 19 2001 3817-3827
2. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer Adjuvant systemic therapy for women with node-negative breast cancer Can Med Assoc J 158 1998
3. G.N. Hortobagyi Treatment of breast cancer New Engl J Med 339 1998 974-984
4. J.P.A. Baak H. van Dop P.H.J. Kurver J. Hermans The value of morphometry to classic prognosticators in breast cancer Cancer 56 1985 374-382
5. J.P.A. Baak Mitosis counting in tumors Hum Pathol 21 1990 683-685
6. I. Jannink P.J. van Diest J.P.A. Baak Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: Classical and random mitotic activity assessments with correction for volume percentage of epithelium Hum Pathol 26 1995 1086-1092
7. P.J. van Diest J.P.A. Baak P. Matze-Cok Reproducibility of mitosis counting in 2469 breast cancer specimens: Results from the multicenter morphometric mammary carcinoma project Hum Pathol 23 1992 603-607
8. F. Clayton Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor Cancer 68 1991 1309-1317
9. C.W. Elston I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up Histopathology 19 1991 403-410
10. A.A. Keshgegian A. Cnaan Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferation cell nuclear antigen, Ki-67 and MIB-1 Am J Clin Pathol 104 1995 42-49
11. P. Manders P. Bult C.G.J. Sweep V.C.G. Tjan-Heijnen L.V.A.M. Beex The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy Breast Cancer Res Treat 77 2002 77-84
12. P. Kronqvist T. Kuopio Y. Collan Morphometric grading in breast cancer: thresholds for mitotic counts Hum Pathol 29 1998 1462-1468
13. R.P.R. Groenendijk P. Bult L. Tewarie P.G.M. Peer R.F. van der Sluis T.J.M. Ruers T. Wobbes Screen-detected breast cancers have a lower mitotic activity index Br J Cancer 82 2000 381-384
14. E. Bergers I. Jannink P.I. van Diest M.A. Cuesta S. Meyer J.C. van Mourik J.P.A. Baak The influence of fixation delay on mitotic activity and flow cytometric cell cycle variables Hum Pathol 28 1997 95-100
15. H. Tsuda F. Akiyama M. Kurosumi G. Sakamoto K. Yamashiro T. Oyama T. Hasebe K. Kameyama T. Hasegawa S. Umemura K. Honma T. Ozawa K. Sasaki H. Morino S. Ohsumi Evaluation of the interobserver agreement in the number of mitotic figures of breast carcinomas as simulation of quality monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol Jpn J Cancer Res 91 2000 451-457
16. M. Barry S.K. Sinha M.B. Leader E.W. Kay Poor agreement in recognition of abnormal mitoses: Requirement for standardized and robust definitions Histopathology 38 2001 68-72
17. T.J. O'Leary M.W. Steffes Can you count on the mitotic index? Hum Pathol 27 1996 147-151
18. A.N. Mirza N.Q. Mirza G. Vlastos S.E. Singletary Prognostic factors in node-negative breast cancer. A review of studies with sample size more than 200 and follow-up more than 5 years Ann Surg 235 2002 10-26
19. S. Aaltomaa P. Lipponen M. Eskelinen et al. Mitotic indexes as prognostic predictors in female breast cancer J Cancer Res Clin Oncol 118 1992 75-81
20. A.D. Thor S. Liu D.H. Moore et al. Comparison of mitotic index, in vitro bromodeoxyuridine labeling and MIB-1 assays to quantitate proliferation in breast cancer J Clin Oncol 17 1999 470-477
21. P.C. Clahsen C.J. van der Velde C. Duval et al. The utility of mitotic index, estrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer Eur J Surg Oncol 25 1999 356-363
22. D.L. Page R. Gray C. Allred L.G. Dressler A.K. Hatfield S. Martino N.J. Robert W.C. Wood Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry. An Eastern Cooperative Oncology Group Study (2192) Am J Clin Oncol 24 2001 10-18
23. M. Schumacher C. Schmoor W. Sauerbrei A. Schauer L. Ummenhofer W. Gatzemeier H. Rauschecker The prognostic effect of histological tumor grade in node-negative breast cancer patients Breast Cancer Res Treat 25 1993 235-245
24. P.J. van Diest J.P. Baak The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients Hum Pathol 22 1991 326-330